Immunological response to re-infections with clones of the colombian strain of trypanosoma cruzi with different degrees of virulence: Influence on pathological features during chronic infection in mice

Memorias do Instituto Oswaldo Cruz

Volumn 110, Issue 4, 2015, Pages 500-506

  da Silva Guerreiro, Marcos Lazaro ^a   Morais, Isa Rita Brito ^a   Andrade, Sonia Gumes ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Clones; DTH; Myocarditis; Re infections; Serology; T. cruzi

Indexed keywords

ANIMALIA; MUS; TRYPANOSOMA CRUZI;

PARASITE ANTIGEN;

ANIMAL; CELLULAR IMMUNITY; CHAGAS DISEASE; CHRONIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; MOLECULAR CLONING; MOUSE; MYOCARDITIS; PARASITEMIA; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; TRYPANOSOMA CRUZI; VIRULENCE;

ANIMALS; ANTIGENS, PROTOZOAN; CHAGAS DISEASE; CHRONIC DISEASE; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNITY, CELLULAR; MICE; MYOCARDITIS; PARASITEMIA; TRYPANOSOMA CRUZI; VIRULENCE;

EID: 84930832534     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-02760140286     Document Type: Article

References (24)

1. Andrade SG 1974. Caracterização de cepas do Trypanosoma cruzi isoladas no Recôncavo Baiano. Rev Patol Trop 3: 121-165.
2. Andrade SG, Campos RF, Sobral KSC, Magalhães JB, Guedes RSP, Guerreiro MLS 2006. Reinfections with different strain of Trypanosoma cruzi as a factor of aggravation of myocarditis and myositis in mice. Rev Soc Bras Med Trop 39: 1-8.
3. Andrade SG, Campos RF, Steindel M, Guerreiro ML, Magalhães JB, de Almeida MC, Reis JN, Santos VC, Valadares HMS, dos Reis MG, Macedo AM 2011. Biological, biochemical and molecular features of Trypanosoma cruzi strains isolated from patients infected through oral transmission during a 2005 outbreak in the state of Santa Catarina, Brazil: its correspondence with the new T. cruzi Taxonomy Consensus (2009). Mem Inst Oswaldo Cruz 106: 948-956.
4. Andrade SG, Magalhães JB 1997. Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. Rev Soc Bras Med Trop 30: 27-35.
5. Andrade V, Barral-Netto M, Andrade SG, Magalhães JB 1985. Aspectos imunológicos da infecção de seis linhagens isogênicas de camundongos por três diferentes cepas do Trypanosoma cruzi. Mem Inst Oswaldo Cruz 80: 203-211.
6. Andrade V, Brodskyn C, Andrade SG 1983. Correlation between isoenzyme patterns and biological behavior of different strains of Trypanosoma cruzi. Trans R Soc Trop Med Hyg 77: 796-799.
7. Andrade ZA, Andrade SG, Sadigursky M 1987. Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide. Am J Pathol 127: 467-473.
8. Anonymus 1999. Recomendations from a satellite meeting. Mem Inst Oswaldo Cruz 94 (Suppl. I): 429-432.
9. Bustamante JM, Rivarcia HW, Fernandez AR, Enders JE, Fretes R, Palma JÁ, Paglini-Oliva PA 2003. Indeterminate Chagas disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy. Clin Sci 104: 415-420.
10. Camandaroba ELP, Campos RF, Magalhães JB, Andrade SG 2001. Clonal structure of Trypanosoma cruzi Colombian strain (biodeme type III): biological, isoenzymic and histopathological analysis of seven isolated clones. Rev Soc Bras Med Trop 34: 151-157.
11. Camandaroba ELP, Pinheiro LCM, Andrade SG 2002. Oral transmission of Chagas disease: importance of Trypanosoma cruzi biodeme in the intragastric experimental infection. Rev Inst Med Trop Sao Paulo 44: 97-103.
12. Camargo ME 1966. Fluorescent antibody test for the diagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev Inst Med Trop Sao Paulo 8: 227-234.
13. Campos RMF, Andrade SG 1996. Characterization of subpopulations (clones and subclones) of the 21SF strain of Trypanosoma cruzi after long lasting maintenance in the laboratory. Mem Inst Oswaldo Cruz 91: 795-800.
14. Coura JR 2013. Chagas disease: control, elimination and eradication. Is it possible? Mem Inst Oswaldo Cruz 108: 962-967.
15. Dias JCP, Silveira AC, Schofield CJ 2002. The impact of Chagas disease control in Latin America - A Review. Mem Inst Oswaldo Cruz 97: 603-612.
16. dos Santos DM, Talvani A, Guedes PM, Machado-Coelho GL, de Lana M, Bahia MT 2009. Trypanosoma cruzi: genetic diversity influences the profile of immunoglobulins during experimental infection. Exp Parasitol 121: 8-14.
17. Federici EE, Abelman WE, Neva FA 1964. Chronic and progressive myocarditis in C3H mice infected with Trypanosoma cruzi. Am J Trop Med Hyg 3: 272-280.
18. Lutsiak CME, Semnani RT, Pascalis R, Kashmiri SVS, Schiom J, Sabzevari H 2005. Inhibition of CD4+25 T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 105: 2862-2868.
19. Macedo V 1976. Influência da exposição à reinfecção na evolução da doença de Chagas. Rev Patol Trop 5: 33-116.
20. Murata M, Suzuki T, Midorikawa K, Oikawa S, Kawanishi S 2004. Oxidative DNA damage induced by a hydroperoxide derivative of cyclophosphamide. Free Radic Biol Med 37: 793-802.
21. Pereira IR, Vilar-Pereira G, da Silva AA, Lannes-Vieira J 2014. Severity of chronic experimental Chagas heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease. Mem Inst Oswaldo Cruz 109: 289-298.
22. Shevach EM, McHugh RS, Piccirillo CA, Thornton AM 2001. Control of T-cell activation by CD4+CD25+ suppessor T cells. Immunol Rev 182: 58-67.
23. Thé TS, Portella RS, Guerreiro ML, Andrade SG 2013. Effect of treatment with cyclophosphamide in low doses upon the onset of delayed type hypersensitivity in mice chronically infected with Trypanosoma cruzi: involvement of heart interstitial dendritic cells. Mem Inst Oswaldo Cruz 108: 691-698.
24. Warren LG 1960. Metabolism of Schizotrypanum cruzi Chagas. I. Effect of culture age and substrate concentration on respiratory rate. J Parasitol 46: 529-539.